product summary
company name :
BD Biosciences
other brands :
Transduction Laboratories, PharMingen, Difco
product type :
antibody
product name :
TCR β chain
catalog :
553166
quantity :
0.5 mg
price :
255.00 USD
clonality :
monoclonal
host :
hamsters
conjugate :
nonconjugated
clone name :
H57-597
reactivity :
mouse
application :
flow cytometry
more info or order :
citations: 123
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat Immunol. 2006;7:819-26 pubmed
|
Åšmieszek A, Czyrek A, Basińska K, Trynda J, SkaradziÅ„ska A, SiudziÅ„ska A, et al. Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line. Biomed Res Int. 2015;2015:769402 pubmed publisher
| |
Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007;204:2803-12 pubmed
| |
Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, de Alboran I, Nakayama K, et al. Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med. 2007;204:2875-88 pubmed
| |
Naeher D, Daniels M, Hausmann B, Guillaume P, Luescher I, Palmer E. A constant affinity threshold for T cell tolerance. J Exp Med. 2007;204:2553-9 pubmed
| |
Shimizu K, Kurosawa Y, Taniguchi M, Steinman R, Fujii S. Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med. 2007;204:2641-53 pubmed
| |
Loeser S, Loser K, Bijker M, Rangachari M, van der Burg S, Wada T, et al. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells. J Exp Med. 2007;204:879-91 pubmed
| |
Anderson C, Oukka M, Kuchroo V, Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med. 2007;204:285-97 pubmed
| |
Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med. 2007;204:41-7 pubmed
| |
Harada M, Magara Koyanagi K, Watarai H, Nagata Y, Ishii Y, Kojo S, et al. IL-21-induced Bepsilon cell apoptosis mediated by natural killer T cells suppresses IgE responses. J Exp Med. 2006;203:2929-37 pubmed
| |
Krueger A, Garbe A, von Boehmer H. Phenotypic plasticity of T cell progenitors upon exposure to Notch ligands. J Exp Med. 2006;203:1977-84 pubmed
| |
Garbe A, Krueger A, Gounari F, Zuniga Pflucker J, von Boehmer H. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med. 2006;203:1579-90 pubmed
| |
Aifantis I, Bassing C, Garbe A, Sawai K, Alt F, von Boehmer H. The E delta enhancer controls the generation of CD4- CD8- alphabetaTCR-expressing T cells that can give rise to different lineages of alphabeta T cells. J Exp Med. 2006;203:1543-50 pubmed
| |
Hayes S, Love P. Stoichiometry of the murine gammadelta T cell receptor. J Exp Med. 2006;203:47-52 pubmed
| |
Yu Q, Park J, Doan L, Erman B, Feigenbaum L, Singer A. Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection. J Exp Med. 2006;203:165-75 pubmed
| |
Bhattacharya D, Rossi D, Bryder D, Weissman I. Purified hematopoietic stem cell engraftment of rare niches corrects severe lymphoid deficiencies without host conditioning. J Exp Med. 2006;203:73-85 pubmed
| |
Fahlén L, Read S, Gorelik L, Hurst S, Coffman R, Flavell R, et al. T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J Exp Med. 2005;201:737-46 pubmed
| |
Pasquier B, Yin L, Fondaneche M, Relouzat F, Bloch Queyrat C, Lambert N, et al. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med. 2005;201:695-701 pubmed
| |
Mandal M, Borowski C, Palomero T, Ferrando A, Oberdoerffer P, Meng F, et al. The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med. 2005;201:603-14 pubmed
| |
Delgado P, Alarcon B. An orderly inactivation of intracellular retention signals controls surface expression of the T cell antigen receptor. J Exp Med. 2005;201:555-66 pubmed
| |
Khodoun M, Orekhova T, Potter C, Morris S, Finkelman F. Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med. 2004;200:857-70 pubmed
| |
Wilson E, Butcher E. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med. 2004;200:805-9 pubmed
| |
Aliahmad P, O Flaherty E, Han P, Goularte O, Wilkinson B, Satake M, et al. TOX provides a link between calcineurin activation and CD8 lineage commitment. J Exp Med. 2004;199:1089-99 pubmed
| |
Jahng A, Maricic I, Aguilera C, Cardell S, Halder R, Kumar V. Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J Exp Med. 2004;199:947-57 pubmed
| |
Street S, Hayakawa Y, Zhan Y, Lew A, MacGregor D, Jamieson A, et al. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J Exp Med. 2004;199:879-84 pubmed
| |
Tupin E, Nicoletti A, Elhage R, Rudling M, Ljunggren H, Hansson G, et al. CD1d-dependent activation of NKT cells aggravates atherosclerosis. J Exp Med. 2004;199:417-22 pubmed
| |
Galkina E, Tanousis K, Preece G, Tolaini M, Kioussis D, Florey O, et al. L-selectin shedding does not regulate constitutive T cell trafficking but controls the migration pathways of antigen-activated T lymphocytes. J Exp Med. 2003;198:1323-35 pubmed
| |
Boehm T, Scheu S, Pfeffer K, Bleul C. Thymic medullary epithelial cell differentiation, thymocyte emigration, and the control of autoimmunity require lympho-epithelial cross talk via LTbetaR. J Exp Med. 2003;198:757-69 pubmed
| |
Bosselut R, Guinter T, Sharrow S, Singer A. Unraveling a revealing paradox: Why major histocompatibility complex I-signaled thymocytes "paradoxically" appear as CD4+8lo transitional cells during positive selection of CD8+ T cells. J Exp Med. 2003;197:1709-19 pubmed
| |
Voyle R, Beermann F, Lees R, Schumann J, Zimmer J, Held W, et al. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D. J Exp Med. 2003;197:919-25 pubmed
| |
Chun T, Page M, Gapin L, Matsuda J, Xu H, Nguyen H, et al. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells. J Exp Med. 2003;197:907-18 pubmed
| |
Yu Q, Erman B, Bhandoola A, Sharrow S, Singer A. In vitro evidence that cytokine receptor signals are required for differentiation of double positive thymocytes into functionally mature CD8+ T cells. J Exp Med. 2003;197:475-87 pubmed
| |
Caramalho I, Lopes Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med. 2003;197:403-11 pubmed
| |
Tanimura N, Nagafuku M, Minaki Y, Umeda Y, Hayashi F, Sakakura J, et al. Dynamic changes in the mobility of LAT in aggregated lipid rafts upon T cell activation. J Cell Biol. 2003;160:125-35 pubmed
| |
Hoffmann P, Ermann J, Edinger M, Fathman C, Strober S. Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002;196:389-99 pubmed
| |
Street S, Trapani J, MacGregor D, Smyth M. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med. 2002;196:129-34 pubmed
| |
Haks M, Pépin E, van den Brakel J, Smeele S, Belkowski S, Kessels H, et al. Contributions of the T cell receptor-associated CD3gamma-ITAM to thymocyte selection. J Exp Med. 2002;196:1-13 pubmed
| |
Panigada M, Porcellini S, Barbier E, Hoeflinger S, Cazenave P, Gu H, et al. Constitutive endocytosis and degradation of the pre-T cell receptor. J Exp Med. 2002;195:1585-97 pubmed
| |
Chung D, Chitnis T, Panzo R, Kasper D, Sayegh M, Tzianabos A. CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med. 2002;195:1471-8 pubmed
| |
Sasada T, Touma M, Chang H, Clayton L, Wang J, Reinherz E. Involvement of the TCR Cbeta FG loop in thymic selection and T cell function. J Exp Med. 2002;195:1419-31 pubmed
| |
Pellicci D, Hammond K, Uldrich A, Baxter A, Smyth M, Godfrey D. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage. J Exp Med. 2002;195:835-44 pubmed
| |
Singh A, Wilson M, Hong S, Olivares Villagómez D, Du C, Stanic A, et al. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med. 2001;194:1801-11 pubmed
| |
Schneider P, Takatsuka H, Wilson A, Mackay F, Tardivel A, Lens S, et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med. 2001;194:1691-7 pubmed
| |
Belkaid Y, Hoffmann K, Mendez S, Kamhawi S, Udey M, Wynn T, et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med. 2001;194:1497-506 pubmed
| |
Ikarashi Y, Mikami R, Bendelac A, Terme M, Chaput N, Terada M, et al. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. J Exp Med. 2001;194:1179-86 pubmed
| |
Gibbons D, Douglas N, Barber D, Liu Q, Sullo R, Geng L, et al. The biological activity of natural and mutant pTalpha alleles. J Exp Med. 2001;194:695-703 pubmed
| |
Chun T, Serbina N, Nolt D, Wang B, Chiu N, Flynn J, et al. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J Exp Med. 2001;193:1213-20 pubmed
| |
Wong P, Barton G, Forbush K, Rudensky A. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J Exp Med. 2001;193:1179-87 pubmed
| |
Schmedt C, Tarakhovsky A. Autonomous maturation of alpha/beta T lineage cells in the absence of COOH-terminal Src kinase (Csk). J Exp Med. 2001;193:815-26 pubmed
| |
Fehniger T, Suzuki K, Ponnappan A, VanDeusen J, Cooper M, Florea S, et al. Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med. 2001;193:219-31 pubmed
| |
Anderton S, Radu C, Lowrey P, Ward E, Wraith D. Negative selection during the peripheral immune response to antigen. J Exp Med. 2001;193:1-11 pubmed
| |
Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernandez C, et al. Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med. 2000;192:1645-52 pubmed
| |
Ellmeier W, Jung S, Sunshine M, Hatam F, Xu Y, Baltimore D, et al. Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk. J Exp Med. 2000;192:1611-24 pubmed
| |
Bhandoola A, Dolnick B, Fayad N, Nussenzweig A, Singer A. Immature thymocytes undergoing receptor rearrangements are resistant to an Atm-dependent death pathway activated in mature T cells by double-stranded DNA breaks. J Exp Med. 2000;192:891-7 pubmed
| |
Smyth M, Thia K, Street S, MacGregor D, Godfrey D, Trapani J. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 2000;192:755-60 pubmed
| |
Lohoff M, Duncan G, Ferrick D, Mittrucker H, Bischof S, Prechtl S, et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med. 2000;192:325-36 pubmed
| |
Nishimura H, Yajima T, Naiki Y, Tsunobuchi H, Umemura M, Itano K, et al. Differential roles of interleukin 15 mRNA isoforms generated by alternative splicing in immune responses in vivo. J Exp Med. 2000;191:157-70 pubmed
| |
Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, et al. Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med. 2000;191:105-14 pubmed
| |
Korner H, Cretney E, Wilhelm P, Kelly J, Rollinghoff M, Sedgwick J, et al. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J Exp Med. 2000;191:89-96 pubmed
|
product information
Cat.# :
553166
Brand :
BD Pharmingen
Name :
TCR β chain
Format :
NA/LE
Clone :
H57-597
Isotype :
Ar Ham IgG 2 , λ1
React :
Ms
Conc :
1.0 mg/ml
Apps :
FCM
Size :
0.5 mg
Status :
RUO
List Price :
255.00 USD
more info or order :
company information
BD Biosciences
review
product type
related products
browse more products
questions and comments